KMTS · Kestra Medical Technologies, Ltd.
$28.14
+0.71 (+2.57%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$1.62B
Shares
59.56M
Volume · Oct 5
146.65K
Avg daily vol (3M)
369.39K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$27.43
Open$27.52
Day$26.81–27.83
52W close$17.87–28.46
Avg vol 30d373K
Short int3.1M · 5.2% float · 8.3d
Short vol75%
Last earningsSep 14, 2026
DataMar 2025–Oct 2026
Filing10-Q · Sep 14
Up next
Next earnings call
Dec 17, 2026
Est · unconfirmed
· in 10 wks
filed Sep 14, 2026
call held Jul 14, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$106.73M
Trailing 12 months
Net income (TTM)
−$149.87M
Trailing 12 months
Revenue growth YoY
+59.9%
Year over year
Operating margin
-134.5%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-7.6%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$126.42M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+14.2%
Year over year · more shares
Price change (1Y)
+12.6%
Trailing year
Short interest
5.2%
Latest settlement · 8.3 days to cover
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Strong Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15.3 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+16%
above
Price vs 50-day avg
+7%
above
RSI (14)
58
neutral
MACD trend
Positive
52-week position
90%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+9%
trailing
6-month return
+46%
trailing
YTD return
+3%
this year
Relative strength
+34%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $26 › 200d $24 — 50d above 200d
Institutional flow
Flat
1 of 108 funds reported for Sep 30 · net 0 sh shares
Insider flow
Distributing
Net -$4.7M over 90 days · 100% sells
Short interest
Rising
5.24% of float · ▲ +5.1% MoM · 8.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
108 holders — near 1-yr high, broad support
Squeeze score
67
elevated · 0–100
Fundamentals
Revenue growth
+59%
Y/Y
Gross margin
51%
expanding
EPS growth
+53%
Y/Y
Free cash flow
$-116.6M
Quant / Vol
risk profile
Volatility
62%
annualized · 1-yr
Max drawdown
−36%
past year
ATR
5.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Sep 14, 2026
FY27 revenue guidance
· fiscal year 2027
Initiated
$141M
prior FY $95.13M
midpoint +48.2% Y/Y
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+16%
Bullish
Price vs 50-day avg
+7%
Bullish
RSI (14)
58
Neutral
MACD trend
Positive
Bullish
52-week position
90%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $26 › 200d $24 — 50d above 200d
Institutional flow
Flat
1 of 108 funds reported for Sep 30 · net 0 sh shares
Insider flow
Distributing
Net -$4.7M over 90 days · 100% sells
Short interest
Rising
5.24% of float · ▲ +5.1% MoM · 8.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
108 holders — near 1-yr high, broad support
Price context
position in its 52-week range
Range low $18
Now $27 · 90%
Range high $28
vs 200-day avg +16%
vs 50-day avg +7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted operating expenses non-GAAP | $44.2M | Three Months Ended July 31, 2026 | — |
| Total liquidity | $320M | As of July 31, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
KMTS
this stock
Kestra Medical Technologies, Ltd.
|
$1.62B | +3.4% | +59.0% | — | 5.2% |
|
ISRG
Intuitive Surgical Inc
|
$143.14B | -30.8% | +20.5% | 46.5 | 2.3% |
|
BDX
Becton Dickinson & Co
|
$49.57B | — | +8.2% | — | 4.2% |
|
MDLN
Medline Inc.
|
$45.62B | -15.2% | +11.5% | — | 3.1% |
|
RMD
Resmed Inc
|
$32.02B | -9.1% | +13.4% | 21.3 | 9.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| KMTS | +1.1% | +9.1% | +46.2% | -3.0% | +3.4% |
| SPY | -0.2% | -0.5% | +12.2% | +0.9% | +12.9% |
| vs SPY | +1.3% | +9.6% | +34.0% | -4.0% | -9.4% |